Arcus Biosciences, Inc.

RCUS

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001724521

SEC filings (opens in a new tab)

In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Arcus Biosciences, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of RCUS: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	172	1	193	+22
Shares	52.9M	47.3K	51.9M	−875.9K (−1.7%)
Value	$997.7M	$893.0K	$790.9M	−$205.9M (−20.7%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (43)

Institutions that held Arcus Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to RCUS in Q2 2024
Institution	Shares	Value	% of portfolio
Millennium Management LLC	175,705	$2.68M	0.00%
Gsa Capital Partners LLP	159,108	$2.42M	0.17%
Ikarian Capital, LLC	145,000	$2.21M	0.69%
Verition Fund Management LLC	89,611	$1.36M	0.01%
Cubist Systematic Strategies, LLC	84,463	$1.29M	0.02%
ExodusPoint Capital Management, LP	58,951	$898.0K	0.01%
Capula Management Ltd	55,709	$848.4K	0.01%
HRT Financial LP	46,579	$709.0K	0.00%
Boothbay Fund Management, LLC	44,529	$678.2K	0.02%
XTX Topco Ltd	38,761	$590.3K	0.05%
Corebridge Financial, Inc.	31,548	$480.5K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	31,265	$475.9K	0.00%
Brevan Howard Capital Management LP	30,963	$471.6K	0.03%
Engineers Gate Manager LP	28,992	$441.5K	0.01%
Point72 Asia (Singapore) Pte. Ltd.	26,677	$406.3K	0.08%
Corton Capital Inc.	24,221	$368.9K	0.19%
Bayesian Capital Management, LP	24,100	$367.0K	0.04%
Teza Capital Management LLC	23,705	$361.0K	0.04%
Jacobs Levy Equity Management, Inc	23,608	$359.6K	0.00%
Capstone Investment Advisors, LLC	21,847	$332.7K	0.01%
Sherbrooke Park Advisers LLC	19,767	$301.1K	0.05%
Dynamic Technology Lab Private Ltd	17,722	$270.0K	0.03%
ClariVest Asset Management LLC	17,092	$260.3K	0.03%
Bridgefront Capital, LLC	16,721	$254.7K	0.11%
Squarepoint Ops LLC	16,700	$254.3K	0.00%
Seelaus Asset Management LLC	13,000	$198.0K	0.20%
Y-Intercept (Hong Kong) Ltd	11,754	$179.0K	0.01%
First Trust Advisors LP	10,575	$161.1K	0.00%
STRS Ohio	6,900	$105.1K	0.00%
Lazard Asset Management LLC	5,862	$89.0K	0.00%
Aquatic Capital Management LLC	5,800	$88.3K	0.00%
Point72 (DIFC) Ltd	5,461	$83.2K	0.01%
EntryPoint Capital, LLC	5,004	$76.2K	0.04%
Catalyst Funds Management Pty Ltd	4,400	$67.0K	0.02%
Innealta Capital, LLC	4,338	$66.1K	0.02%
Coppell Advisory Solutions LLC	1,413	$21.5K	0.00%
Chris Bulman Inc	464	$7.07K	0.00%
Ronald Blue Trust, Inc.	285	$5.38K	0.00%
Versant Capital Management, Inc	139	$2.12K	0.00%
Asset Dedication, LLC	100	$1.52K	0.00%
Smartleaf Asset Management LLC	13	$197	0.00%
Huntington National Bank	9	$137	0.00%
DiNuzzo Private Wealth, Inc.	1	$16	0.00%

Sold out (21)

Institutions that held Arcus Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of RCUS in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Eventide Asset Management, LLC	240,000	$4.53M
Fred Alger Management, LLC	73,498	$1.39M
Texas Permanent School Fund	47,086	$889.0K
Campbell & CO Investment Adviser LLC	37,496	$707.9K
Dark Forest Capital Management LP	35,590	$671.9K
Cresset Asset Management, LLC	34,848	$657.9K
Jump Financial, LLC	32,190	$607.7K
Mirae Asset Global Investments Co., Ltd.	32,356	$583.0K
American International Group, Inc.	29,014	$547.8K
New York Life Investment Management LLC	21,416	$404.3K
Martingale Asset Management L P	19,825	$374.3K
Walleye Capital LLC	17,691	$334.0K
E Fund Management Co., Ltd.	16,052	$303.1K
ProShare Advisors LLC	10,846	$204.8K
Headlands Technologies LLC	3,139	$59.3K
Metropolitan Life Insurance Co	2,870	$54.2K
Quarry LP	2,750	$51.9K
KBC Group NV	1,952	$37.0K
Signaturefd, LLC	67	$1.26K
Riggs Asset Managment Co. Inc.	19	$359
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	10	$188

Not filed for Q2 2024 yet (1)

Institutions that held Arcus Biosciences, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCUS in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	47,298	$893.0K